These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35118731)

  • 21. Uterine inflammatory myofibroblastic tumor with THBS1-INSR fusion.
    Sim A; Devouassoux-Shisheboran M; Benmoulay-Rigollot C; Picot T; Péoc'h M; Karpathiou G
    Pathol Res Pract; 2023 Jun; 246():154500. PubMed ID: 37156213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vocal cord inflammatory myofibroblastic tumor with mucoid deposits harboring TIMP3-ALK fusion: A potential diagnostic pitfall.
    Yorita K; Togashi Y; Nakagawa H; Miyazaki K; Sakata S; Baba S; Takeuchi K; Hayashi Y; Murakami I; Kuroda N; Oda Y; Kohashi K; Yamada Y; Kiyozawa D; Michal M; Michal M
    Pathol Int; 2019 Jun; 69(6):366-371. PubMed ID: 31215130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1-ALK fusion: a case report.
    Honda K; Kadowaki S; Kato K; Hanai N; Hasegawa Y; Yatabe Y; Muro K
    Invest New Drugs; 2019 Aug; 37(4):791-795. PubMed ID: 30790150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fusion of dynactin 1 to anaplastic lymphoma kinase in inflammatory myofibroblastic tumor.
    Wang X; Krishnan C; Nguyen EP; Meyer KJ; Oliveira JL; Yang P; Yi ES; Erickson-Johnson MR; Yaszemski MJ; Maran A; Oliveira AM
    Hum Pathol; 2012 Nov; 43(11):2047-52. PubMed ID: 22658521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FN1: a novel fusion partner of ALK in an inflammatory myofibroblastic tumor.
    Ouchi K; Miyachi M; Tsuma Y; Tsuchiya K; Iehara T; Konishi E; Yanagisawa A; Hosoi H
    Pediatr Blood Cancer; 2015 May; 62(5):909-11. PubMed ID: 25682942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraocular inflammatory myofibroblastic tumor with ALK overexpression.
    O'Malley DP; Poulos C; Czader M; Sanger WG; Orazi A
    Arch Pathol Lab Med; 2004 Jan; 128(1):e5-7. PubMed ID: 14692830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.
    Mossé YP; Lim MS; Voss SD; Wilner K; Ruffner K; Laliberte J; Rolland D; Balis FM; Maris JM; Weigel BJ; Ingle AM; Ahern C; Adamson PC; Blaney SM
    Lancet Oncol; 2013 May; 14(6):472-80. PubMed ID: 23598171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory myofibroblastic tumour of the jaw: A rare presentation.
    Monteiro L; Alhassani M; Resende T; Albuquerque R
    J Stomatol Oral Maxillofac Surg; 2020 Feb; 121(1):90-94. PubMed ID: 30825659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory myofibroblastic tumour of the urinary bladder: the role of immunoglobulin G4 and the comparison of two immunohistochemical antibodies and fluorescence in-situ hybridization for the detection of anaplastic lymphoma kinase alterations.
    Choi E; Williamson SR; Montironi R; Zhang S; Wang M; Eble JN; Grignon DJ; Lopez-Beltran A; Idrees MT; Baldridge LA; Scarpelli M; Jones CL; Wang L; MacLennan GT; Osunkoya AO; Cheng L
    Histopathology; 2015 Jul; 67(1):20-38. PubMed ID: 25406945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DCTN1-ALK gene fusion in inflammatory myofibroblastic tumor (IMT) of the CNS.
    Vidrine DW; Berry JF; Garbuzov A; Falcon C; Tubbs RS; Bui CJ
    Childs Nerv Syst; 2021 Jul; 37(7):2147-2151. PubMed ID: 34014367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel LRRFIP1-ALK fusion in inflammatory myofibroblastic tumor of hip and response to crizotinib.
    Liu W; Duan Q; Gong L; Yang Y; Huang Z; Guo H; Niu X
    Invest New Drugs; 2021 Feb; 39(1):278-282. PubMed ID: 32915420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inflammatory myofibroblastic tumor].
    Leuschner I
    Pathologe; 2010 Mar; 31(2):106-8. PubMed ID: 20063099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anaplastic lymphoma kinase inhibitor therapy in the treatment of inflammatory myofibroblastic tumors in pediatric patients: Case reports and literature review.
    Craig E; Wiltsie LM; Beaupin LK; Baig A; Kozielski R; Rothstein DH; Li V; Twist CJ; Barth M
    J Pediatr Surg; 2021 Dec; 56(12):2364-2371. PubMed ID: 33676744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TERT promoter mutation analysis as a surrogate to morphology and immunohistochemistry in problematic spindle cell lesions of the urinary bladder.
    Bertz S; Stöhr R; Gaisa NT; Wullich B; Hartmann A; Agaimy A
    Histopathology; 2020 Dec; 77(6):949-962. PubMed ID: 32645760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subepithelial rectal gastrointestinal stromal tumor - the use of endoscopic ultrasound-guided fine needle aspiration to establish a definitive cytological diagnosis: a case report.
    Brunaldi VO; Coronel M; Chacon DA; De Moura ET; Matuguma SE; De Moura EG; De Moura DT
    J Med Case Rep; 2017 Mar; 11(1):59. PubMed ID: 28259173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory myofibroblastic tumor versus IgG4-related sclerosing disease and inflammatory pseudotumor: a comparative clinicopathologic study.
    Yamamoto H; Yamaguchi H; Aishima S; Oda Y; Kohashi K; Oshiro Y; Tsuneyoshi M
    Am J Surg Pathol; 2009 Sep; 33(9):1330-40. PubMed ID: 19718789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall.
    Kataoka TR; Yamashita N; Furuhata A; Hirata M; Ishida T; Nakamura I; Hirota S; Haga H; Katsuyama E
    World J Surg Oncol; 2014 Jun; 12():186. PubMed ID: 24938355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case report: Pharmacology and resistance patterns of three generations of ALK inhibitors in metastatic inflammatory myofibroblastic sarcoma.
    Parker BM; Parker JV; Lymperopoulos A; Konda V
    J Oncol Pharm Pract; 2019 Jul; 25(5):1226-1230. PubMed ID: 29925295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dramatic response to alectinib in inflammatory myofibroblastic tumor with anaplastic lymphoma kinase fusion gene.
    Saiki M; Ohyanagi F; Ariyasu R; Koyama J; Sonoda T; Nishikawa S; Kitazono S; Yanagitani N; Horiike A; Ninomiya H; Ishikawa Y; Nishio M
    Jpn J Clin Oncol; 2017 Dec; 47(12):1189-1192. PubMed ID: 28977547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory Myofibroblastic Tumor (IMT) of the Trachea Excised by Transtracheal Surgery: Case Report.
    Ohba S; Matsumoto F; Kojima M; Fujimaki M; Fukumura Y; Ikeda K
    Ear Nose Throat J; 2023 Aug; 102(8):511-515. PubMed ID: 34006125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.